Skip to main content

Neuropathology of multiple sclerosis lesions relevant to cerebrospinal fluid abnormalities

  • Conference paper
Cerebrospinal Fluid Analysis in Multiple Sclerosis
  • 83 Accesses

Abstract

Multiple Sclerosis (MS) is the commonest organic disease of the Central Nervous System (CNS) in the young adult throughout the temperate zone. The hallmark is the demyelinating plaque, in which the removal of apparently normal myelin from axons, usually against a background of perivenular infiltration by lymphocytes, plasma cells and mononuclear cells, is observed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Schelling F (1986) Damaging venous reflux into the skull or spine: relevance to multiple sclerosis. Medical Hypotheses 21: 141–148

    Article  PubMed  CAS  Google Scholar 

  2. Peress NS, Siegelman J, Fleit HB (1987) High avidity periventricular IgG-Fc receptor activity in human and rabbit brain. Clin Immunol Immunopathol 42: 229–238

    Article  PubMed  CAS  Google Scholar 

  3. Greenfield JG, Norman RM (1963) Demyelinating diseases. In: Blackwood W, McMenemey WH, Meyer A, Norman RM, Russell DS (eds) Greenfield’s Neuropathology. 2nd ed, Edward Arnold, London, pp 475–519

    Google Scholar 

  4. Sanders V, Conrad AJ, Tourtellotte WW (1993) On classification of postmortem multiple sclerosis plaques for neuroscientists. J Neuroimmunol 46: 207–216

    Article  PubMed  CAS  Google Scholar 

  5. Raine CS, Traugott U (1990) The pathology of the myelinated axon. In: Adachi M and Sher JH (eds) Current Trends in Neurosciences-Neuromuseular diseases. Igaku-Shoin, New York, pp 229–275

    Google Scholar 

  6. Adams CWM, Abdulla YH, Torres EM, Poston RN (1987) Periventricular plaques in multiple sclerosis: their perivenous origin and relationship to granular ependymitis. Neu-ropathol Appl Neurobiol 13: 141–152

    Article  CAS  Google Scholar 

  7. Prineas JW, Connell F (1979) Remyelination in multiple sclerosis. Ann Neurol 5: 22–31

    Article  PubMed  CAS  Google Scholar 

  8. Raine CS, Scheinberg LC (1988) On the immunopathology of plaque development and repair in multiple sclerosis. J Neuroimmunol 20: 189–201

    Article  PubMed  CAS  Google Scholar 

  9. Selmaj K, Brosnan CF, Raine CS (1991) Colocalization of lymphocytes bearing gamma delta receptor and heat shock protein hsp65 + oligodendrocytes in multiple sclerosis. Proc Natl Acad Sci 88: 6452–6456

    Article  PubMed  CAS  Google Scholar 

  10. Gerritse K, Deen C, Fasbender M, Ravid R, Boersma W, Claassen E(1994) The involvement of specific anti myelin basic protein antibody forming cells in multiple sclerosis immunopathology. J Neuroimmunol 49: 153–159

    Google Scholar 

  11. Noronha ABC, Richman DP, Arnason BGW (1980) Detection of in vivo stimulated cerebrospinal fluid lymphocytes by flow cytometry in patients with multiple sclerosis. New Eng J Med 303: 713–717

    Article  PubMed  CAS  Google Scholar 

  12. Tournier-Lasserve E, Lyon-Caen O, Roullet E, Bach MA (1987) IL 2 receptor and HLA Class 2 antigens on cerebrospinal fluid cells of patients with multiple sclerosis and other neurological diseases. Clin Exp Immunol 67: 581–586

    PubMed  CAS  Google Scholar 

  13. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH (1995) B71 and B72 costimulatory molecules activate differentially the Thl/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80: 707–718

    Article  PubMed  CAS  Google Scholar 

  14. De Simone R, Giampaolo A, Giometto B, Gallo P, Levi G, Peschle C, Aloisi F (1995) The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J Neuropathol Exp Neurol 54: 175–187

    Article  PubMed  Google Scholar 

  15. Hafler DA, Weiner HL (1995) Immunologic mechanisms and therapy in multiple sclerosis. Immunological Reviews 144: 75–107

    Article  PubMed  CAS  Google Scholar 

  16. Romagnani S (1994) Lymphokine production by human T cells in disease states. Ann Rev Immunol 12: 227–257

    Article  CAS  Google Scholar 

  17. Gallo P, Piccinno M, Pagni S, Tavolato B (1988) Interleukin 2 levels in serum and cerebrospinal fluid of multiple sclerosis patients. Ann Neurol 24: 795–797

    Article  PubMed  CAS  Google Scholar 

  18. Trotter JL, Collins KG, Van der Veen R (1991) Serum cytokine levels in chronic progressive multiple sclerosis. Interleukin 2 levels parallel tumor necrosis factor alpha levels. J Neuroimmunol 33: 29–36

    Article  PubMed  CAS  Google Scholar 

  19. Hintzen RQ, Van Lier RAW, Kuijpers KC, Baars PA, Schaasberg W, Lucas CJ, Polman CH (1991) Elevated levels of a soluble form of the T cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol 35: 211–217

    Article  PubMed  CAS  Google Scholar 

  20. Olsson T, Wang WZ, Hojeberg B, Kostulas V, Jiang YP, Andersson G, Ekre HR, Link KH (1990) Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon gamma. J Clin Invest 86: 981–985

    Article  PubMed  CAS  Google Scholar 

  21. Selmaj K, Raine CS, Cannella B, Brosnan CF (1991) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87: 949–954

    Article  PubMed  CAS  Google Scholar 

  22. Lassmann H, Brunner C, Bradl M, Linington C (1988) Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol 75: 566–576

    Article  PubMed  CAS  Google Scholar 

  23. Walsh MJ, Tourtellotte WW (1986) Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis. J Exp Med 163: 41–53

    Article  PubMed  CAS  Google Scholar 

  24. Prineas JW, Wright RG (1978) Macrophages, lymphocytes and plasmacells in the perivascular compartment in chronic multiple sclerosis. Lab Invest 38: 409–421

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Italia, Milano

About this paper

Cite this paper

Mancardi, G.L., Capello, E. (1996). Neuropathology of multiple sclerosis lesions relevant to cerebrospinal fluid abnormalities. In: Cerebrospinal Fluid Analysis in Multiple Sclerosis. Springer, Milano. https://doi.org/10.1007/978-88-470-2205-8_2

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2205-8_2

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2207-2

  • Online ISBN: 978-88-470-2205-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics